Irritable Bowel Syndrome Therapy Tablet, Orally Disintegrating
FDA Label NDC 17312-019

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Trp Company for the product Irritable Bowel Syndrome Therapy (NDC 17312-019). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, warnings, otc - stop use, otc - pregnancy or breast feeding, directions, other information, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Purpose

Asafoetida HPUS - Bloating, Cramping

Bismuthum subnitricum HPUS - Irritation

Bryonia HPUS - Dry, hard stools

Carbo vegetabilis HPUS - Indigestion, Belching

Lycopodium Clavatum HPUS - Loose stools, Flatulence

Natrum carbonicum HPUS - Stomach discomfort

Nux vomica HPUS - Irritability

Veratrum album HPUS - Irregularity

Otc - Pregnancy Or Breast Feeding

If pregnant or breast-feeding, ask a health professional before use.

Other Information

  • There are no known contraindications.
  • Active ingredients are micro-diluted in accordance with the Homeopathic Pharmacopoeia of the United States and are therefore non-toxic with no known side effects.
  • Store in a cool dark location.
  • Irritable Bowel Syndrome Therapy™ Homeopathic Fast Dissolving Tablet are homeopathic dilutions: see www.thereliefproducts.com for details.

Inactive Ingredients

Advantol® 300, Lactose, Magnesium Stearate, Mannitol, Microcrystalline Cellulose.

Otc - Questions

www.thereliefproducts.com, 1-888-969-6855

* Please review the disclaimer below.